Sofia, Bulgaria, November 29, 2024 – According to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (the Company, SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that with the completion of the respective due dilligence procedures the first stage ot the transaction for acquisition of a pharmaceutical product portfolio consisting of CHC and prescription products.